| |
|
|
|
Synthetic Biologics Inc  
|
|
0.5574 -0.002 (-0%) |
08-13 16:00 |
|
Open: |
0.56 |
Pre close: |
0.5593 |
Target:
|
0.76
|
|
High: |
0.5701 |
Low: |
0.5501 |
Resistance:
|
0.65
0.75
|
|
Volume: |
83,088 |
Market Cap: |
11M |
Support:
|
0.49
0.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.58
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
0.57  |
Signal(12,26,9): |
0.02 |
|
MA(100): |
0.43 |
Stochastic Oscillator |
%K(14,3):
|
23.48 |
|
MA(250): |
0.44 |
%D(3): |
28.03 |
|
Average Volume(K) |
3-Month: |
64548
|
52-Week |
High:
|
0.75 |
|
10-Days: |
59095 |
Low: |
0.25 |
|
RSI |
RSI(14):
|
50.44 |
Change(%): |
42.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.925 |
Return on Equity (ttm) |
-93.9 |
Shares Out. (M) |
18.26 |
|
EPS Est. Current Year |
-0.170 |
Return on Assets (ttm) |
-49.1 |
Shares Float (M) |
18.13 |
|
EPS Est. Next Year |
-0.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.13 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
8.72 |
|
Forward EPS |
-4.060 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
20 |
|
Book Value (p.s.) |
-0.290 |
EBITDA (p.s.) |
-0.815 |
P/E |
-0.60 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.92 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.61 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-9.08 |
P/CF |
-0.70 |
|
|
|
|
|
|
